MCA Stability Tool
Find stability recommendations for tablets and capsules.
Product Search
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.7mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 700microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.7mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 700microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.7mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 700microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.7mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 700microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.088mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 88microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.088mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 88microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.088mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 88microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.088mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 88microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.088mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 88microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.088mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 88microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.088mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 88microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.088mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 88microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.088mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 88microgram tablets (Accord Healthcare Ltd).
Use with caution
Stability Notes
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in an MCA.
Provenance
This compatibility recommendation is derived from Mirapexin 0.088mg tablets (Boehringer Ingelheim Ltd) and Pramipexole 88microgram tablets (Accord Healthcare Ltd).
No Stability Information
Stability Notes